John C Reed Johnson & Johnson (JNJ) insider trading activity

John C Reed is EVP, Innovative Medicine, R&D of JOHNSON & JOHNSON. Currently has a direct ownership of 10,658 shares of JNJ, which is worth approximately $1.74 Million. The most recent transaction as insider was on Jul 17, 2025, when has been sold 19,137 shares (Common Stock) at a price of $163.55 per share, resulting in proceeds of $3,129,856. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.7K

31.42% 3M change

7.94% 12M change

Total Value Held $1.74 Million

JOHN C REED Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 17 2025	SELL Open market or private sale	$3,129,856 $163.55 p/Share	19,137 Reduced 64.23%	10,658 Common Stock
May 01 2025	SELL Payment of exercise price or tax liability	$1,719,722 $156.31 p/Share	11,002 Reduced 26.97%	29,795 Common Stock
May 01 2025	BUY Exercise of conversion of derivative security	-	25,255 Added 38.24%	40,797 Common Stock
Feb 18 2025	SELL Payment of exercise price or tax liability	$60,117 $156.15 p/Share	385 Reduced 2.42%	15,542 Common Stock
Feb 15 2025	BUY Exercise of conversion of derivative security	-	1,350 Added 7.81%	15,927 Common Stock
May 01 2024	SELL Payment of exercise price or tax liability	$1,588,176 $144.59 p/Share	10,984 Reduced 48.69%	11,577 Common Stock
May 01 2024	BUY Exercise of conversion of derivative security	-	22,255 Added 49.66%	22,561 Common Stock

JCR

John C Reed

EVP, Innovative Medicine, R&D

New Brunswick, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JNJ shares.

Notify only if

Value

Insider Trading

Get notified when an Johnson & Johnson insider buys or sells JNJ shares.

Notify only if

Operation

Value

Type

News

Receive news related to JOHNSON & JOHNSON

Track Activities on JNJ

Account